We are international
Donate
TEXT SIZE   


ASH 2012: Dr. Kumar - Phase I/II, Multicenter, Open-Label, Dose-Escalation Study of Bendamustine in Combination with Lenalidomide and Dexamethasone (BRD) in Patients with Relapsed Multiple Myeloma: A Multiple Myeloma Research Consortium Study
Shaji Kumar,
Mayo Clinic
Rochester, MN
12.02.12


To view the video full screen, click on the small button next to the volume control in the lower right hand corner.

 related articles